TY - JOUR
T1 - Patient-responsive protein biomarkers for cartilage degeneration and repair identified in the infrapatellar fat pad
AU - Emanuel, Kaj S
AU - Huang, Luojiao
AU - Haartmans, Mirella J J
AU - Sanmartin Martinez, Javier
AU - Zijta, Frank
AU - Heeren, Ron M A
AU - Kerkhoffs, Gino M M J
AU - Emans, Pieter J
AU - Cillero-Pastor, Berta
PY - 2024
Y1 - 2024
N2 - OBJECTIVES: Cartilage defects (CDs) are regarded as early manifestation of osteoarthritis (OA). The infrapatellar fat pad (IPFP) is an important mediator in maintaining joint homeostasis, disease progression and tissue repair, with a crucial role of its secreted proteins. Here, we investigate the proteome of the IPFP in relation to clinical status and response to surgical treatment of CDs. METHODS: In order to characterize the proteome of the IPFP, samples from a cohort of 53 patients who received surgical treatment for knee CDs were analyzed with label-free proteomics. Patients were divided based on validated outcome scores for pain and knee function, preoperatively and at 1-year postoperatively, and on MRI assessment of the defect severity, fibrosis and synovitis. RESULTS: Specific proteins were differentially abundant in patients with MRI features and better clinical outcome after CD surgery, including a downregulation of cartilage intermediate layer protein 2 (CILP-2) and microsomal glutathione s-transferase 1 (MGST1), and an upregulation of aggrecan (ACAN), and proteoglycan 4 (PRG4). Pathways related to cell interaction, oxidation and matrix remodeling were altered. CONCLUSION: Proteins in the IPFP that have a function in extracellular matrix, inflammation and immunomodulation were identified as potentially relevant markers for cartilage repair monitoring.
AB - OBJECTIVES: Cartilage defects (CDs) are regarded as early manifestation of osteoarthritis (OA). The infrapatellar fat pad (IPFP) is an important mediator in maintaining joint homeostasis, disease progression and tissue repair, with a crucial role of its secreted proteins. Here, we investigate the proteome of the IPFP in relation to clinical status and response to surgical treatment of CDs. METHODS: In order to characterize the proteome of the IPFP, samples from a cohort of 53 patients who received surgical treatment for knee CDs were analyzed with label-free proteomics. Patients were divided based on validated outcome scores for pain and knee function, preoperatively and at 1-year postoperatively, and on MRI assessment of the defect severity, fibrosis and synovitis. RESULTS: Specific proteins were differentially abundant in patients with MRI features and better clinical outcome after CD surgery, including a downregulation of cartilage intermediate layer protein 2 (CILP-2) and microsomal glutathione s-transferase 1 (MGST1), and an upregulation of aggrecan (ACAN), and proteoglycan 4 (PRG4). Pathways related to cell interaction, oxidation and matrix remodeling were altered. CONCLUSION: Proteins in the IPFP that have a function in extracellular matrix, inflammation and immunomodulation were identified as potentially relevant markers for cartilage repair monitoring.
KW - Cartilage repair
KW - KOOS
KW - VAS
KW - biomarkers
KW - mass spectrometry
KW - proteomics
U2 - 10.1080/14789450.2024.2438774
DO - 10.1080/14789450.2024.2438774
M3 - Article
SN - 1478-9450
VL - 21
SP - 563
EP - 573
JO - Expert Review of Proteomics
JF - Expert Review of Proteomics
IS - 12
ER -